Evidence map›Paper›PMID 40827744›Full record

ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2025

Application of the ADEM definition to cerebral attacks of MOG antibody-associated disease.

Sara J Hooshmand, Nisa Vorasoot, Xiaoyang Li, John J Chen, Vyanka Redenbaugh, Samantha A Banks, Laura Cacciaguerra, Cristina Valencia-Sanchez, Sebastian Lopez Chiriboga, Elia Sechi and 8 more

Abstract read
In one paragraph

Article in Multiple sclerosis (Houndmills, Basingstoke, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sara J HooshmandDepartments of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.ORCID 0000-0001-7826-4362
Nisa VorasootDepartments of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.ORCID 0000-0002-0751-8967
Xiaoyang LiDepartments of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
John J ChenDepartments of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.ORCID 0000-0003-3644-7528
Vyanka RedenbaughDepartments of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.ORCID 0000-0001-6400-7760
Samantha A BanksDepartments of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Laura CacciaguerraDepartments of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Cristina Valencia-SanchezDepartment of Neurology, Mayo Clinic Arizona, Scottsdale, AZ, USA.ORCID 0000-0003-0116-8035
Sebastian Lopez ChiribogaDepartment of Neurology, Mayo Clinic College of Medicine and Science, Jacksonville, FL, USA.ORCID 0000-0001-5653-5600
Elia SechiDepartments of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.ORCID 0000-0003-4698-663X
Jan-Mendelt TillemaDepartments of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Deena TajfirouzDepartments of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Michael BassoPsychiatry, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Todd A HardyDepartment of Neurology, Concord Repatriation General Hospital, Sydney, NSW, Australia.
Nanthaya TisavipatDepartments of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.ORCID 0000-0002-4021-6450
Kai GuoDepartments of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Sean J PittockDepartments of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Eoin P FlanaganDepartments of Neurology and Center for MS and Autoimmune Neurology Mayo Clinic College of Medicine and Science, Rochester, MN, USA.ORCID 0000-0002-6661-2910

Funding

Utilizing epidemiology, imaging and fluid biomarkers in MOG antibody-associated disease to inform prognosis, pathogenesis and therapeuticsR01NS113828 · NINDS · MAYO CLINIC ROCHESTER · PI Eoin P Flanagan · 2020 to 2026
$2.4M
NINDS NIH HHS R01 NS113828
6 · The paper itself

Abstract

backgroundAcute disseminated encephalomyelitis (ADEM) is a demyelinating syndrome observed in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) but there are limited data on application of this definition to its cerebral attacks or in adults with this disease.

methodsWe analyzed patients from the Mayo Clinic MOGAD cohort (

resultsWe identified 89 patients (children, 34; adults, 55) and 55/89 (62%) were of female sex. Acute magnetic resonance imaging (MRI) abnormalities included: poorly demarcated T2 lesions (white matter, 85 (96%); deep gray matter, 41 (46%); T1-hypointense lesions (42 (47%)). Forty-two patients did not fulfill the ADEM definition due to: monofocal syndrome, 9; or no encephalopathy, 33. The remaining 47 patients (53%: children, 27/34 (79%); adults, 20/55 (36%)) fulfilled the ADEM definition, and 14 had preceding attacks, and 34 had subsequent attacks relative to ADEM episode. The features in children and adults with ADEM were broadly comparable.

conclusionApplying the ADEM definition to MOGAD cerebral attacks highlighted that an update of the 2013 ADEM definition would be beneficial and could explicitly state its application to both adults and children and allow it to be applied to attacks at any time during the disease course.

Indexed as

Demyelinating Autoimmune Diseases, CNSEncephalomyelitis, Acute DisseminatedMyelin-Oligodendrocyte GlycoproteinAdolescentAdultAgedAutoantibodiesChildChild, PreschoolFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMyelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYoung AdultAutoantibodiesMOG protein, humanMyelin-Oligodendrocyte Glycoproteinacute disseminated encephalomyelitisencephalitisMOGMOGADMyelin oligodendrocyte glycoprotein antibody-associated disease

Identifiers

PMID40827744
PMCPMC12421408

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.